Javascript must be enabled to continue!
Predilatation Prior to Transcatheter Aortic Valve Implantation: Is it Still a Prerequisite?
View through CrossRef
Predilatation has been historically considered a mandatory step before transcatheter aortic valve implantation (TAVI) since it facilitates valve crossing and prosthesis delivery, ensures optimal valve expansion and improves hemodynamic stability during valve deployment. However, as a result of procedural evolution over time, direct TAVI (without pre-implantation balloon aortic valvuloplasty) has emerged as an interesting option to simplify the procedure and to avoid potential valvuloplasty-related complications. Several real-world retrospective studies and one small randomised study have shown that direct TAVI (with both self-expanding and balloon-expandable prostheses) is feasible, safe and associated with outcomes similar to standard TAVI with pre-implantation balloon aortic valvuloplasty. In the absence of high-quality, robust evidence, the current review aims to discuss the advantages and disadvantages of omitting predilatation prior to TAVI.
Title: Predilatation Prior to Transcatheter Aortic Valve Implantation: Is it Still a Prerequisite?
Description:
Predilatation has been historically considered a mandatory step before transcatheter aortic valve implantation (TAVI) since it facilitates valve crossing and prosthesis delivery, ensures optimal valve expansion and improves hemodynamic stability during valve deployment.
However, as a result of procedural evolution over time, direct TAVI (without pre-implantation balloon aortic valvuloplasty) has emerged as an interesting option to simplify the procedure and to avoid potential valvuloplasty-related complications.
Several real-world retrospective studies and one small randomised study have shown that direct TAVI (with both self-expanding and balloon-expandable prostheses) is feasible, safe and associated with outcomes similar to standard TAVI with pre-implantation balloon aortic valvuloplasty.
In the absence of high-quality, robust evidence, the current review aims to discuss the advantages and disadvantages of omitting predilatation prior to TAVI.
Related Results
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Abstract
Background
Surgical aortic valve replacement has been the treatment of choice for patients with aortic valve disease be...
AORTIC ROOT ANEURYSM OR ECTASIA TREATED WITH AORTIC ROOT WRAPPED PROCEDURE
AORTIC ROOT ANEURYSM OR ECTASIA TREATED WITH AORTIC ROOT WRAPPED PROCEDURE
Objectives
To develop a relatively simple and effective and less risk operation, aortic root wrapped procedure, to treat with aortic root aneurysm or ectasia.
...
Valve-Sparing Aortic Root Replacement by Congenital Heart Surgeons: A Single Center Experience.
Valve-Sparing Aortic Root Replacement by Congenital Heart Surgeons: A Single Center Experience.
Background Aortic root dilatation and aortic insufficiency can
occur in patients with prior conotruncal defect surgery, the Ross
procedure, and connective tissue disease (CTD). Val...
e0541 Percutaneous valved stent implantation above the coronary ostia: a new transitional treatment for acute aortic valve rupture
e0541 Percutaneous valved stent implantation above the coronary ostia: a new transitional treatment for acute aortic valve rupture
Objective
To investigate the feasibility of percutaneous valved stent implantation above the coronary ostia as a transitional treatment for acute aortic valve rup...
Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Pathology: Current Evidence and Technical Challenges
Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Pathology: Current Evidence and Technical Challenges
Transcatheter aortic valve implantation (TAVI) is an established therapy for severe symptomatic aortic valve stenosis (AS) in patients at high and intermediate risk for surgical ao...
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Abstract
Background
The moving forward indication of transcatheter aortic valve implantation (TAVI) to younger aortic valve sten...
Prevalence of Patients With Severe Aortic Stenosis, Low Flow And Preserved Ejection Fraction: Results From a Cath-Lab Data Base.
Prevalence of Patients With Severe Aortic Stenosis, Low Flow And Preserved Ejection Fraction: Results From a Cath-Lab Data Base.
AbstractRecent echocardiographic studies described that almost 30% of patients with severe aortic valve stenosis on the basis of aortic valve area may paradoxically have a relative...
Permanent Pacemaker Implantation Following Aortic Valve Replacement: Current Prevalence and Clinical Predictors
Permanent Pacemaker Implantation Following Aortic Valve Replacement: Current Prevalence and Clinical Predictors
Background:
The incidence of conduction disease requiring permanent pacemaker (PPM) implantation following aortic valve replacement (AVR) ranges from 3% to 6%....

